{
  "ptid_time": "068_S_4431_2012-02-06",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4431/2012-02-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 62,330 mm³, 61.8% above the reference mean. With a Z-score of 1.48 (93.1th percentile), this represents mild enlargement; hippocampal volume measures 6,756 mm³, 10.6% below the reference mean. With a Z-score of -1.04 (15.0th percentile), this represents mild atrophy; whole brain volume measures 1,036,450 mm³, 4.0% below the reference mean. With a Z-score of -0.52 (30.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,947 mm³, 28.1% below the reference mean. With a Z-score of -1.91 (2.8th percentile), this represents moderate atrophy; fusiform gyrus volume measures 19,942 mm³, 5.9% above the reference mean. With a Z-score of 0.50 (69.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,353 mm³, 14.0% below the reference mean. With a Z-score of -1.26 (10.4th percentile), this represents mild atrophy. ",
  "text_data": "Age is 74.1 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Neurologic; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Alcohol Abuse; Smoking; Major Surgical Procedures. MMSE: 28.0. MoCA: 27.0. Logical Memory: 10.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.88 SUVR (profound elevated); Amyloid beta: 618.50 pg/mL (mild reduced); Total tau: 158.20 pg/mL (mild reduced); Phosphorylated tau: 14.89 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild ventricular enlargement and mild-to-moderate atrophy in key Alzheimer’s-related regions (hippocampus, entorhinal cortex, middle temporal gyrus), alongside elevated amyloid (AV45) and mildly reduced Aβ. However, cognitive scores (MMSE 28, MoCA 27) remain intact, and APOE4-negative status reduces genetic risk.  \n**Diagnosis:** **MCI** (structural and biomarker changes suggest early neurodegeneration, but preserved cognition rules out dementia).  \n**Confidence:** **Medium** (biomarkers and atrophy support pathology, but high cognitive scores are atypical for progression to dementia).  \n\n*Note: Given the discrepancy between imaging/biomarkers and cognitive performance, follow-up monitoring for decline is warranted.*",
  "timestamp": "2025-07-26T09:02:40.256250"
}